PMID- 34871961 OWN - NLM STAT- MEDLINE DCOM- 20220321 LR - 20220321 IS - 2352-3964 (Electronic) IS - 2352-3964 (Linking) VI - 74 DP - 2021 Dec TI - Resistance to TST/IGRA conversion in Uganda: Heritability and Genome-Wide Association Study. PG - 103727 LID - S2352-3964(21)00521-1 [pii] LID - 10.1016/j.ebiom.2021.103727 [doi] LID - 103727 AB - BACKGROUND: Pulmonary tuberculosis (TB) is one of the most deadly pathogens on earth. However, the majority of people have resistance to active disease. Further, some individuals, termed resisters (RSTRs), do not develop traditional latent tuberculosis (LTBI). The RSTR phenotype is important for understanding pathogenesis and preventing TB. The host genetic underpinnings of RSTR are largely understudied. METHODS: In a cohort of 908 Ugandan subjects with genome-wide data on single nucleotide polymorphisms, we assessed the heritability of the RSTR phenotype and other TB phenotypes using restricted maximum likelihood estimation (REML). We then used a subset of 263 RSTR and LTBI subjects with high quality phenotyping and long-term follow-up to identify DNA variants genome-wide associated with the RSTR phenotype relative to LTBI subjects in a case-control GWAS design and annotated and enriched these variants to better understand their role in TB pathogenesis. RESULTS: The heritability of the TB outcomes was very high, at 55% for TB vs. LTBI and 50.4% for RSTR vs. LTBI among HIV- subjects, controlling for age and sex. We identified 27 loci associated with the RSTR phenotype (P<5e-05) and our annotation and enrichment analyses suggest an important regulatory role for many of them. INTERPRETATION: The heritability results show that the genetic contribution to variation in TB outcomes is very high and our GWAS results highlight variants that may play an important role in resistance to infection as well as TB pathogenesis as a whole. CI - Copyright (c) 2021 The Author(s). Published by Elsevier B.V. All rights reserved. FAU - McHenry, Michael L AU - McHenry ML AD - Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. FAU - Benchek, Penelope AU - Benchek P AD - Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. FAU - Malone, LaShaunda AU - Malone L AD - Department of Medicine, Case Western Reserve University, Cleveland, OH, USA. FAU - Nsereko, Mary AU - Nsereko M AD - Department of Medicine, School of Medicine, Makerere University, Kampala, Uganda. FAU - Mayanja-Kizza, Harriet AU - Mayanja-Kizza H AD - Department of Medicine, School of Medicine, Makerere University, Kampala, Uganda. FAU - Boom, W Henry AU - Boom WH AD - Department of Medicine, Case Western Reserve University, Cleveland, OH, USA. FAU - Williams, Scott M AU - Williams SM AD - Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. FAU - Hawn, Thomas R AU - Hawn TR AD - Department of Medicine, University of Washington, Seattle, WA, USA. FAU - Stein, Catherine M AU - Stein CM AD - Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA; Department of Medicine, Case Western Reserve University, Cleveland, OH, USA. LA - eng GR - R01 AI124348/AI/NIAID NIH HHS/United States GR - TL1 TR002549/TR/NCATS NIH HHS/United States GR - U01 AI115642/AI/NIAID NIH HHS/United States GR - R33 AI138272/AI/NIAID NIH HHS/United States GR - N01AI70022/AI/NIAID NIH HHS/United States GR - N01AI95383/AI/NIAID NIH HHS/United States GR - T32 HL007567/HL/NHLBI NIH HHS/United States GR - T32 GM007250/GM/NIGMS NIH HHS/United States PT - Journal Article DEP - 20211204 PL - Netherlands TA - EBioMedicine JT - EBioMedicine JID - 101647039 SB - IM MH - Adolescent MH - Adult MH - Aged MH - Case-Control Studies MH - Child MH - Child, Preschool MH - *Drug Resistance MH - Female MH - Genome-Wide Association Study MH - High-Throughput Nucleotide Sequencing MH - Humans MH - Latent Tuberculosis/*genetics MH - Likelihood Functions MH - Male MH - Middle Aged MH - Phenotype MH - *Polymorphism, Single Nucleotide MH - *Quantitative Trait, Heritable MH - Sequence Analysis, DNA MH - Tuberculosis, Pulmonary/drug therapy/*genetics MH - Uganda MH - Young Adult PMC - PMC8652006 OTO - NOTNLM OT - GWAS OT - M. tuberculosis OT - TB outcomes OT - phenotype definition OT - resistance to tuberculosis infection COIS- Declaration of Competing Interest The authors have no conflicts of interest to report. EDAT- 2021/12/07 06:00 MHDA- 2022/03/22 06:00 PMCR- 2021/12/04 CRDT- 2021/12/06 20:23 PHST- 2021/07/21 00:00 [received] PHST- 2021/11/17 00:00 [revised] PHST- 2021/11/17 00:00 [accepted] PHST- 2021/12/07 06:00 [pubmed] PHST- 2022/03/22 06:00 [medline] PHST- 2021/12/06 20:23 [entrez] PHST- 2021/12/04 00:00 [pmc-release] AID - S2352-3964(21)00521-1 [pii] AID - 103727 [pii] AID - 10.1016/j.ebiom.2021.103727 [doi] PST - ppublish SO - EBioMedicine. 2021 Dec;74:103727. doi: 10.1016/j.ebiom.2021.103727. Epub 2021 Dec 4.